Maartje van den Biggelaar/sanquin.nl
Aug 2, 2026, 08:27
Maartje van den Biggelaar: HemoTwin Opens Doors for Aspiring Researchers
Maartje van den Biggelaar, Head of Laboratory of Proteomics at Sanquin, Lecturer of Pharmaceutical Biotechnology at Utrecht University, shared a post on LinkedIn:
“Within the national phramework of HemoTwin, we are looking for 3 PhD students to advance precision hemostasis in congenital bleeding disorders and bleeding disorders of unknown cause using mass spectrometry-based proteomics.
Join our team!”
Stay updated with Hemostasis Today.
-
Sep 20, 2026, 09:51Ceasovschih Alexandr: A Closer Look at Lipid Disorders in CKM Syndrome
-
Sep 20, 2026, 09:05World Stroke Academy: Can Adjunct IAT Improve Tissue Reperfusion?
-
Sep 20, 2026, 06:46Neeraj Songara: From Donated Blood to Engineered Therapeutics
-
Sep 20, 2026, 06:24Louise St. Germain Bannon: Improving Awareness and Care for Women Across the Lifespan
-
Sep 20, 2026, 05:17Maxime Dely: When ABO Compatibility Isn’t Enough for Safe Transfusion
-
Sep 20, 2026, 04:54William Aird: What Does a Complete History and Physical Really Mean?
-
Sep 20, 2026, 04:34Hons Saurabh Kaushik: Why Uncontrolled LDL Can Be Harmful
-
Sep 20, 2026, 03:58Salih Ehsan: The Complexities of HbF and HbA2
-
Sep 20, 2026, 03:22The Voices of People Living With Bleeding Disorders – EHC